Wordt geladen...
A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity
Immunotherapy with chimeric antigen receptor T (CAR-T cells) has been recently approved for patients with relapsed/refractory B-lymphoproliferative neoplasms. Along with great efficacy in patients with poor prognosis, CAR-T cells have been also linked with novel toxicities in a significant portion o...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7312228/ https://ncbi.nlm.nih.gov/pubmed/32485958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21113886 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|